Regulation and Therapeutic Targeting of MTHFD2 and EZH2 in KRAS-Mutated Human Pulmonary Adenocarcinoma.
Saved in:
| Title: | Regulation and Therapeutic Targeting of MTHFD2 and EZH2 in KRAS-Mutated Human Pulmonary Adenocarcinoma. |
|---|---|
| Authors: | Li Y; Institute of Pathology, University Medical Center, 37075 Göttingen, Germany., Elakad O; Institute of Pathology, University Medical Center, 37075 Göttingen, Germany.; Department of Internal Medicine 2, Goethe University Hospital, 60590 Frankfurt, Germany., Yao S; Institute of Pathology, University Medical Center, 37075 Göttingen, Germany.; Department of Pathology, The 3rd Xiangya Hospital, Central South University, Changsha 410013, China., von Hammerstein-Equord A; Department of Thoracic and Cardiovascular Surgery, University Medical Center, 37075 Göttingen, Germany., Hinterthaner M; Department of Thoracic and Cardiovascular Surgery, University Medical Center, 37075 Göttingen, Germany., Danner BC; Department of Thoracic and Cardiovascular Surgery, University Medical Center, 37075 Göttingen, Germany., Ferrai C; Institute of Pathology, University Medical Center, 37075 Göttingen, Germany., Ströbel P; Institute of Pathology, University Medical Center, 37075 Göttingen, Germany., Küffer S; Institute of Pathology, University Medical Center, 37075 Göttingen, Germany., Bohnenberger H; Institute of Pathology, University Medical Center, 37075 Göttingen, Germany. |
| Source: | Metabolites [Metabolites] 2022 Jul 15; Vol. 12 (7). Date of Electronic Publication: 2022 Jul 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101578790 Publication Model: Electronic Cited Medium: Print ISSN: 2218-1989 (Print) Linking ISSN: 22181989 NLM ISO Abbreviation: Metabolites Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2218-1989 |
|---|---|
| DOI: | 10.3390/metabo12070652 |
